Reliability of Friedewald formula in patients with type 2 diabetes mellitus and its relation to lipid profile in diabetes regulation

被引:2
作者
Keti, Didem Barlak [1 ]
Muhtaroglu, Sabahattin [1 ]
机构
[1] Erciyes Univ, Med Biochem, Kayseri, Turkey
来源
REVISTA ROMANA DE MEDICINA DE LABORATOR | 2021年 / 29卷 / 02期
关键词
Friedewald formula; LDL cholesterol; type 2 diabetes mellitus; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL-CHOLESTEROL; HDL-CHOLESTEROL; MANAGEMENT; ASSAY; TRIGLYCERIDES; ABNORMALITIES; RATIO; RISK;
D O I
10.2478/rrlm-2021-0007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Many laboratories utilize Friedewald formula (FF) to analyze LDL cholesterol levels of patients including diabetes mellitus (DM). Therefore, it is essential to consider the coherence of results acquired by FF and direct measurement. The number of studies that investigated the effect of lipid parameters, especially TG/ HDL cholesterol ratio, on the difference between the two methods is limited. The study was designed to compare LDL cholesterol values obtained by using FF with direct measurement, and to evaluate the relationship between diabetes regulation and lipid profile. Material and Methods: In the cross-sectional study, 529 type 2 DM patients and 1703 non-DM subjects were divided into four groups regarding TG concentrations. Unlike other studies, the study focuses on direct LDL (DLDL) cholesterol levels obtained with the help of different DLDL cholesterol kits (n=20). The correlations were implemented between HbA1c and lipid profiles. Results: It was determined that the bias% was over 10% in 24% of patients with 100-199 mg/dL TG levels. The parameter revealed that the most significant difference and the strongest correlation with HbA1c was TG/HDL cholesterol ratio in patients with type 2 DM. Conclusions: In patients with type 2 DM, even if it was TG <200 mg/dL, LDL calculated with FF should be evaluated together with the TG/HDL cholesterol ratio. Otherwise, direct measurement can be recommended. This ratio is related to diabetes regulation and may be used to monitor patients..
引用
收藏
页码:179 / 187
页数:9
相关论文
共 31 条
  • [1] Anwar M, 2014, JCPSP-J COLL PHYSICI, V24, P8, DOI 01.2014/JCPSP.0812
  • [2] Babic Nermina, 2019, Med Arch, V73, P163, DOI 10.5455/medarh.2019.73.163-168
  • [3] Does friedewald formula underestimate the risk of ischemic heart disease?
    Bansal E.
    Kaur N.
    [J]. Indian Journal of Clinical Biochemistry, 2014, 29 (4) : 496 - 500
  • [4] Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels
    Boizel, R
    Benhamou, PY
    Lardy, B
    Laporte, F
    Foulon, T
    Halimi, S
    [J]. DIABETES CARE, 2000, 23 (11) : 1679 - 1685
  • [5] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
    Catapano, Alberico L.
    Graham, Ian
    De Backer, Guy
    Wiklund, Olov
    Chapman, M. John
    Drexel, Heinz
    Hoes, Arno W.
    Jennings, Catriona S.
    Landmesser, Ulf
    Pedersen, Terje R.
    Reiner, Zeljko
    Riccardi, Gabriele
    Taskinen, Marja-Riita
    Tokgozoglu, Lale
    Monique, W. M.
    Verschuren, W. M. Monique
    Vlachopoulos, Charalambos
    Wood, David A.
    Luis Zamorano, Jose
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (39) : 2999 - +
  • [6] Chatterjee BP, 2018, INT J CLIN BIOCH RES, V5, P541, DOI [10.18231/2394-6377.2018.0115, DOI 10.18231/2394-6377.2018.0115]
  • [7] Cholesterol Reference Method Laboratory Network (CRMLN), 2006, NAT REF SYST CHOL LD, P1
  • [8] High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease
    da Luz, Protasio Lemos
    Favarato, Desiderio
    Faria-Neto, Jose Rocha, Jr.
    Lemos, Pedro
    Palandri Chagas, Antonio Carlos
    [J]. CLINICS, 2008, 63 (04) : 427 - 432
  • [9] Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low-density lipoprotein cholesterol in diabetic patients with coronary artery disease
    Dong, Qiu-Ting
    Gao, Ying
    Wu, Na-Qiong
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Li, Sha
    Liu, Hui-Hui
    Cao, Ye-Xuan
    Zhang, Hui-Wen
    Zhao, Xi
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
  • [10] Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?
    Enkhmaa, Byambaa
    Prakash, Nishant
    Berglund, Lars
    [J]. ATHEROSCLEROSIS, 2018, 274 : 230 - 231